Having trouble accessing articles? Reset your cache.

China moves to take centralized procurement nationwide

China's Joint Procurement Office will expand its pilot program for centralized procurement of generic and off-patent originator drugs nationwide, a move that could further cut prices of the 25 drugs in the program.

Under the pilot program announced late last year, manufacturers that have passed equivalence testing offered pricing discounts in exchange for guaranteed market share, and contracts were awarded to the lowest

Read the full 622 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE